CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
80,876,778
Share change
+1,576,912
Total reported value
$1,476,031,275
Put/Call ratio
216%
Price per share
$18.25
Number of holders
162
Value change
+$52,536,647
Number of buys
91
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q4 2014

As of 31 Dec 2014, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 162 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,876,778 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, OPPENHEIMER FUNDS INC, VANGUARD GROUP INC, BlackRock Fund Advisors, COLUMBIA WANGER ASSET MANAGEMENT LLC, LORD, ABBETT & CO. LLC, Bank of New York Mellon Corp, State Street Corp, and BlackRock Institutional Trust Company, N.A.. This page lists 162 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.